FULVIGLEN 250MG INJ is a prescription medication used to treat certain types of breast cancer that have progressed or recurred after previous treatment.
Composition:
Each vial of FULVIGLEN 250MG INJ contains 250mg of fulvestrant.
Mechanism of Action:
Fulvestrant works by:
- Binding to the estrogen receptor in cancer cells, which blocks the action of estrogen
- Inhibiting the growth and proliferation of cancer cells
- Causing the death of cancer cells by triggering apoptosis (programmed cell death)
Uses:
FULVIGLEN 250MG INJ is used to treat:
- Hormone-receptor-positive breast cancer that has progressed or recurred after previous treatment
- Hormone-receptor-positive breast cancer that has progressed or recurred after previous treatment with anti-estrogen medications
Dosage:
The recommended dosage of FULVIGLEN 250MG INJ is:
- 500mg administered as an intramuscular injection on days 1 and 15 of a 28-day cycle, followed by 500mg every 28 days
Side Effects:
Common side effects of FULVIGLEN 250MG INJ include:
- Hot flashes
- Fatigue
- Nausea and vomiting
- Diarrhea
- Abdominal pain
- Muscle weakness
- Hair loss
- Increased risk of bone fractures
Recommendation:
FULVIGLEN 250MG INJ is recommended for patients who have not responded to previous treatment for their breast cancer. Patients should also be advised to monitor their blood counts and liver function regularly during treatment.
Important Note:
Patients should not take FULVIGLEN 250MG INJ if they have a history of severe allergic reactions, kidney problems, or liver problems. Patients should also inform their healthcare provider if they have any underlying medical conditions, such as heart problems or lung problems, before taking FULVIGLEN 250MG INJ.
Some common brands of fulvestrant include:
- Faslodex (AstraZeneca)
- Fulvestrant (AstraZeneca)
Please note that FULVIGLEN 250MG INJ is not available in all markets and may be approved for different indications and dosages in different regions.
It’s worth noting that FULVIGLEN 250MG INJ is a hormonal therapy, meaning it works by targeting the estrogen receptor in cancer cells. This can be an effective treatment option for patients with hormone-receptor-positive breast cancer, as it can help to slow or stop the growth of cancer cells.
Reviews
There are no reviews yet.